Bristol Myers Squibb Taps Chai Discovery for AI-Driven Antibody Design
Chai Discovery announced a research collaboration under which Bristol Myers Squibb will use Chai’s molecular-folding and generative-design models to support therapeutic-antibody discovery across its portfolio and help build a continuously learning discovery system. The…
